Contact this trialFirst, we need to learn more about you.
Nucleoside Analog
Venetoclax + Azacitidine for Acute Myeloid Leukemia
Recruiting3 awardsPhase 2
Houston, Texas
This trial tests how well venetoclax and azacitidine work to treat acute myeloid leukemia after stem cell transplant. Venetoclax blocks a protein needed for cancer cell survival, and azacitidine works in different ways to stop the growth of cancer cells. Giving both drugs after stem cell transplant may help control high risk leukemia.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.